Introduction 55
Penile erection depends on a pair of cylindrical corpora cavernosa that run inside the 56 shaft of the penis. Each corpus is a sponge-like structure, consisting of multiple 57 vascular sinuses, fed directly by helicine arteries that branch from the main centrally 58 running cavernosal artery. Erection is achieved by relaxation of smooth muscle cells, 59
both in the walls of the arteries and in the septa that define the sinuses, allowing the 60 latter to fill with blood and expand until restricted by a surrounding fibrous sheath 61 called the tunica albuginea. This causes the intracavernosal pressure to rise and the 62 penile shaft to become rigid (2). In contrast, the normal, flaccid state of the penis 63 depends on smooth muscle contraction, thus restricting filling and expansion of the 64 sinuses. When corpus cavernosum smooth muscle is examined in vitro, it exhibits 65 spontaneous tone and/or spontaneous phasic contractions, both of which are enhanced 66
by -adrenoceptor agonists and sympathetic nerves, and are inhibited by nitric oxide 67 (NO) from parasympathetic nerves and vascular endothelium (2). Hence, modulation 68 of the intrinsic cavernosum smooth muscle contraction provides not only the 69 physiological means to regulate penile erection, but also the pharmacological means 70 to treat erectile dysfunction. 71
Currently the most successful treatment for erectile dysfunction is phosphodiesterase-72 5 (PDE-5) inhibitors, such as sildenafil (14) . These inhibit the corpus cavernosum 73 smooth muscle contraction by blocking metabolism of cGMP, which is the 74 intracellular second messenger synthesized by the smooth muscle cells in response to 75 NO. Although up to 70% of men with erectile dysfunction respond favourably to 76 PDE-5 inhibitors, the remainder are resistant to this treatment. In particular, diabetic 77 males (of whom up to 50% suffer from some degree of erectile dysfunction) have a 78 response rate of only 50% (10). It is important, therefore, to discover new ways of 79 targeting the mechanisms that regulate corpus cavernosum smooth muscle 80 contraction. To do this, it is necessary to further elucidate the physiological 81 mechanisms involved. presumably by inducing membrane hyperpolarization; or where relaxation is impaired 91 in transgenic mice lacking intact BK channels (33) . 92
The depolarizing stimuli that activate the L-type Ca 2+ channels during the 93 detumescent state remain to be fully elucidated, but a prime candidate is I ClCa , the 94 current generated by Ca 2+ -activated Cl -channels (Cl Ca ). I ClCa has been found in rabbit 95 and rat corpus cavernosum smooth muscle cells, where it has been shown to be 96 activated by Ca 2+ release from intracellular stores (11, 21, 31). Activation of these 97 currents occurs both spontaneously or in response to -adrenoceptor stimulation, 98 therefore they could potentially be involved in both spontaneous and catecholamine-99 enhanced contractions. However, establishing their role has been hindered by the fact 100 that effective, selective blockers for I ClCa were not widely available when tension 101 studies were carried out. Traditional I ClCa channel blockers, niflumic acid (NFA) and 102 anthracene-9-carboxylic acid (A9C) increased intracorporal pressure in rats (21) and 103 abolished spontaneous and agonist-induced contractions in RCCSM strips at high 104 concentrations (9). Despite this, these compounds were found to be ineffective 105 blockers of I ClCa in isolated RCCSM cells (11). Furthermore, non-specific effects of 106 these compounds have been described, including blockade of non-specific cation 107 channels, opening of BK Ca channels, interfering with intracellular Ca 2+ release and 108 blocking prostaglandin synthesis (see Discussion for references). 109
It is only relatively recently that the novel protein, TMEM16A/ANO1, has been 110 implicated as the most likely molecular candidate for the Cl Ca (6, 30, 37). As a result 111 of this discovery, more potent novel drugs, have been developed with this target in 112 mind (26). The aim of the present study was to examine the effect of two of these 113 right to obtain a pseudo-linescan, so that the vertical direction (y) corresponds to 169 distance along the cell, the horizontal direction corresponds to time (t), and the 170 intensity (brightness) corresponds to the Ca 2+ level. control, and cDNA was generated from brain-derived RNA as described above. The cycling conditions for qPCR were as follows: an initial 10 minute denaturation at 212 95°C was followed by 40 cycles of denaturation at 95°C for 15 seconds and extension 213 at 60°C for 1 minute. Samples were processed on a QUANTICA real time PCR 214 system (Techne). All samples were analysed in triplicate and non-template controls 215
were included for all primer sets. A dissociation curve (50°C-95°C) was obtained 216 after qPCR acquisition to verify the specificity of each primer set. Validation of 217 TMEM16 A and B, and ß-actin primers was performed using serial dilutions (1 ng -218 0.01 ng) of cDNA from rabbit brain tissue. Standard curves for all three genes were 219 included on every plate. Representative slopes of the standard curves obtained were -220 3.32 and -3.14, for TMEM16A and B, and -3.43 for ß-actin. The data reported 221 translate into primer efficiencies of 100%, 108%, and 96% respectively. 222
End-Point RT-PCR using the qPCR primer sets was also performed using the 223
Amplitaq Gold PCR Master Mix (Applied Biosystems). The thermal cycling 224
conditions for RT-PCR were as follows: an initial 10 minute denaturation at 95°C, 225
followed by 40 cycles of denaturation at 95°C for 15 seconds, annealing at 55°C for 226 15 seconds and extension at 68°C for 1 minute. All reactions were performed in a 227
Techne TC-512 thermal cycler. Amplicons were separated on a 2% agarose gel and 228 visualised upon UV illumination following SYBR Safe (Invitrogen) staining. All PCR 229 fragments were subsequently purified and verified by sequencing. 230
Drugs & Solutions 231
Drugs used were T16A inh A01 and CACC inh A01 (Tocris), both made in 10 mM stock 232 solutions in DMSO and diluted to final concentrations in the experimental set up. 233
Phenylephrine (PE, Sigma) was made as a stock solution in distilled water and diluted 234 to final concentrations in the experimental set up. 235
Solution A (Ca 2+ free Hanks solution for cell dispersal), mM: NaCl (125), KCl (5.4), 236
Glucose (10), Sucrose (2.9), NaHCO 3 (4.2), KH 2 PO 4 (0.4), NaH 2 PO 4 (0.3), HEPES 237 (10). pH was adjusted to 7.4 using NaOH. 
Statistics and analysis 252
Data are presented as the mean ± s.e.m. Unless otherwise stated, statistical differences 253 between the means of control recordings and those made in the presence of drugs 254
were compared using Student's paired t test, taking the p<0.05 level as significant. In 255 cases where groups of more than 2 means were compared, repeated measures 256 ANOVA, followed by Bonferroni's post hoc test was performed. In cases where 257 unpaired, normalised data were compared (Fig. 5B & 5D The effects of CaCC inh -A01 and T16A inh -A01 were examined on current-voltage (I-V) 271 relationships, evoked by the protocol shown in Fig. 1A . This involved holding the cell 272 at -60 mV for 10 s periods, followed by 500 ms test steps ranging from -80 mV to 273 +60 mV, before returning to the holding potential of -60 mV. Typically, this evoked 274 a family of currents that were inward at negative potentials and reversed to outward 275 currents at positive potentials (Fig. 1A, upper record) . These currents activated 276 slowly, reaching their peaks 50-150 ms after the start of the sweep. Large inward tail 277 currents were recorded on returning to the holding potential of -60 mV. Ion 278 substitution experiments have shown previously that these currents are carried by Cl shows the I-V plots for the Cl -current, measured at the end of the 500 ms sweep, so 288 as to avoid contamination with L-type Ca 2+ current (n=7). In the absence of blocker 289 (unfilled circles) the currents activated -40 mV, where they were inward, peaked at -290 20 mV, and reversed at +5 mV to become outward at positive potentials. CaCC inh -291 A01 (filled circles) reduced the currents throughout the voltage range, blocking both 292 outward and inward currents (maximal inward I ClCa was reduced from -436 ± 146 pA 293
to -14 ± 6 pA, n=7, p<0.05; maximal outward I ClCa was reduced from 1479 ± 299 pA 294 to 218 ± 82 pA, n=7, p<0.01). This contrasts with conventional I ClCa blockers, where 295 a previous study found that these reduced outward I ClCa , without having much effect 296 on inward I ClCa in RCCSM (11). The effect of CaCC inh -A01 (10 M) on L-type Ca concentration blocked L-type Ca 2+ current by nearly 50% (Fig. 1D, p<0 .05, n=5; 311 format as in Fig. 1C) . 312
The same protocol as in Fig. 1 was used to examine the effects of T16A inh -A01, 313
another novel blocker of TMEM16A, on both I ClCa and L-type Ca 2+ current (Fig. 2) . 314 However, this concentration of the drug also reduced maximal L-type Ca 2+ current, by 318 46% (Fig. 2C, p<0.05, n=5) . At 30 M T16A inh -A01 abolished I ClCa (data not shown) 319 but at this concentration it reduced maximal L-type Ca 2+ current by 78% (Fig. 2D,  320 p<0.05, n=5). cases the drugs reversibly reduced STIC amplitude to the extent that only very small 328 STICs remained. Summary data is presented for CaCC inh -A01 ( Fig. 3B; n=5) and 329 T16A inh -A01 ( Fig. 3C; n=6) Fig. 4A and 4C. In Fig. 4A , CaCC inh -A01 (10 M) greatly reduced all of 338 the components of activity, while 30 M of the drug almost abolished activity. (Fig. 4B, n=8, p<0 .01, ANOVA) and this was further reduced to 347 97.5 ± 60 mN.min in 30 μM CaCC inh -A01 (Fig. 4B, n=8, p<0.01, ANOVA) . 348
Similarly, 10 μM T16A inh -A01 reduced activity from 5062 ± 1016 mN.min to 2388 ± 349 584 mN.min (n=8, p<0.05, ANOVA), while 30 μM reduced it to 312 ± 222 mN.min 350 (Fig. 4D, n=8, p<0.01 M caused a moderate relaxation. These effects are consistent with the fact that 10 358 M CaCC inh -A01 had little effect on L-type Ca 2+ current, while 30 M significantly 359 reduced this current (see Fig. 1C ). Fig. 5B shows the effect of T16A inh -A01 on a 360
KCl-induced contraction, where both 10 and 30 μM caused clear relaxations. 361
Summary data for both drugs are presented in Fig. 5C , where normalized tension is 362 compared with the effect of the equivalent concentration DMSO used to solubilize the 363 drugs. DMSO controls were obtained from previously published data (16). In the 364 presence of 10 μM CaCC inh -A01, 84% ± 4.6% of the KCl contraction remained, 365 compared to 91% ± 3% in the presence of 0.1% DMSO alone. This difference was not 366 statistically significant (Mann-Whitney test, P>0.05, n=6). However, in the presence 367 of 30 μM CaCC inh -A01, tension was reduced to 45% ± 5.3% of the KCl induced 368 contraction, compared to 81.5% ± 4.6% in 0.3% DMSO (Mann-Whitney test, p<0.01, 369 n=6). In 10 μM T16A inh -A01 tension was reduced to 64.7% ± 7.9% of the KCl 370 induced contraction (Mann-Whitney test, p<0.05, compared to 0.1% DMSO, n=6) a 371 further reduction to 46% ± 6% was seen in the presence of 30 μM T16A inh A01 372 (p<0.01, compared to 0.3% DMSO, n=6). 373
Effect of CaCC inh -A01 and T16A inh -A01 on PE-induced contractions. 374
The effect of both compounds was tested on contractions induced by PE (1 M). 375
First, time controls were carried out to determine how well PE-contractures were 376 maintained ( Fig. 6A & 6B ). Summary data in Fig. 6B show that, even after 100 min, 377 on average, 75% of the PE-induced tension remained (n=6). 378 mN, n=6, p>0.05) . However, the contractions were not so well sustained as in 398 normal Krebs. When 10 μM CaCC inh -A01 was applied to this falling baseline, it did 399 not result in an obvious inflexion in the record (Fig. 7A) . However, CaCC inh -A01 at 400 30 μM did result in an obvious inflexion and relaxed the preparation. In 6 401 preparations, the effect of CaCC inh -A01 at 10 μM were assessed by measuring the 402 contraction amplitude when first applied and then 20 min later. These results are 403 presented in Fig. 7B , where there was an apparent reduction of 35% in response to the 404 drug. However, this effect is likely to be overestimated because of the falling 405 baseline. It is, nevertheless, clear that in Cl --free conditions, CaCC inh -A01 was much 406 less effective at relaxing the tissue than in normal Krebs (compare Fig. 6 , where the 407 lower concentration of 3 μM CaCC inh -A01 was sufficient to relax the PE contracture 408 to baseline in 20 min). 409
Effect of CaCC inh -A01 on PE-induced contractions in

Effect of CaCC inh -A01 and T16A inh -A01 on PE-induced intracellular Ca 2+ signals. 410
These experiments were conducted on isolated cells loaded with Fluo-4 AM. 411
Conditions were similar to the patch clamp experiments described above, with the 412 exception that the cells were not contacted by a patch pipette and consequently were 413 not voltage-clamped. CaCC inh -A01 (Fig. 8B) . In 7 cells the activity was reduced from F/F 0 = 1.69 ± 0.18 to 428 F/F 0 = 1.28 ± 0.23 (p<0.05, n=7). 429
Expression of TMEM16A and TMEM16B transcripts. 430
We investigated the transcriptional expression of TMEM16A and B in rabbit corpus 431 cavernosum using end-point RT-PCR, with rabbit brain as a positive control. As 432 shown in Fig. 9A, TMEM16A and B signals were detected in both corpus 433 cavernosum and rabbit brain. The same primer sets were subsequently used in 434 quantitative real-time PCR (qPCR) investigation of TMEM16A and B expression in 435 rabbit corpus cavernosum. Quantitative real-time PCR data were expressed as ratios 436 of TMEM16A and B to β-actin, used here as an endogenous reference gene. 437
Mean relative transcriptional expressionof TMEM16A and B are plotted in Fig. 9B  438 (expressed as mean ± SEM). Mean TMEM16A expression, relative to β-actin 439 (arbitrary units), was 13.83 x 10 -3 ± 2.44 x 10 -3 (n=3), whereas TMEM16B was 0.52 x 440
10
-3 ± 0.03 x 10 -3 , indicating that TMEM16A mRNA is expressed at ~27 fold higher 441 levels than TMEM16B in the rabbit corpus cavernosum. relaxation, while a deficiency in BK channels, or BK channel blockers make it 458 difficult for the muscle to relax and impair erection (36). The corollary of this 459 argument is that there must be one or more membrane currents capable of exerting a 460 strong depolarizing influence on the membrane potential of corpus cavernosum 461 myocytes to keep the tissue in a detumescent state. A prime candidate for fulfilling 462 this role is I ClCa , as the equilibrium potential for Cl -ions in smooth muscle cells is 463 believed to be close to -24 mV, due to their ability to actively accumulate intracellular 464
Cl
- (1) . Hence opening Cl -channels will bring the membrane potential to within the 465 range where the L-type Ca 2+ channels will open. 466
There is direct evidence from patch clamp studies that corpus cavernosum myocytes 467 from rabbits and rodents express Ca 2+ -activated Cl -channels (11, 13, 21, 28). 468
However, the conventional Cl -channel antagonists, niflumic acid and A9C, were very 469 weak blockers of this current, especially of inward Cl -current, which is the relevant 470 direction for depolarization (11). These compounds also suffer from a variety of 471 unwanted effects, with reports that both drugs interfere with intracellular Ca 2+ release 472 (12), activate BK channels (15, 24, 35) and block cation channels (8, 19, 34), while 473 niflumic acid also blocks T-and L-type Ca 2+ currents (3, 38), fast voltage-dependent 474 Na + current (4, 39), gap junction coupling (24) and has been widely used as a non-475 steroidal anti-inflammatory drug (NSAID) due to its blocking action on cyclo-476 oxygenase-2 (COX-2; 22). Therefore, although high concentrations of these 477 compounds have been reported to reduce catecholamine-and nerve-evoked 478 contractions in rabbit corpus cavernosum (9, 23), and to increase intracorporeal 479 pressure in rats and rabbits (21), their lack of potency and specificity make these 480 experiments difficult to interpret. 481
In the present study, we have re-examined the role of I ClCa in mediating contractions 482 in rabbit corpus cavernosum using two new generation I ClCa blockers. Firstly, we 483 investigated if the targets of these compounds, namely TMEM16A and B were 484 expressed in rabbit corpus cavernosum at transcriptional level. Although there are ten 485 members of the TMEM16 family (A-J), only isoforms A and B have been 486
unequivocally associated with CACC activity [28] , and TMEM16A is most widely 487 believed to be the isoform responsible for I ClCa in smooth muscle (for citations see 488 27). Messenger RNA for both isoforms was present in rabbit corpus cavernosum, 489 with X-fold greater expression of TMEM16A versus TMEM16B, consistent with 490 finding in vascular smooth muscle (27) . 491
Next, we showed that CaCC inh -A01 and T16A inh -A01 were effective blockers of I ClCa , 492 when evoked by depolarizing steps (Figs. 1 & 2) . As it has been shown that T16A inh -493 A01 is less effective at blocking I ClCa when cytosolic Ca 2+ concentration is high (33), 494 it was also important to show that both compounds blocked I ClCa when evoked by 495 physiological rises in intracellular Ca 2+ . It has been previously shown that STICs in 496 the rabbit corpus cavernosum are activated by spontaneous intracellular Ca 2+ waves, 497 due to release from the sarcoplasmic reticulum (28), and are likely to account for the 498 spontaneous physiological depolarizations seen in intracellular microelectrode 499 recordings in whole tissue (17). The fact that both blockers effectively reduced 500
STICs showed, therefore, that they could reduce I ClCa when it was evoked by 501 physiologically relevant Ca 2+ levels. 502
When using CaCC inh -A01 and T16A inh -A01 to evaluate the role of I ClCa in contraction 503 in vitro, it was necessary to examine their effects on L-type Ca 2+ current, because of 504 its importance in both spontaneous and agonist-enhanced contraction. Unfortunately, 505 both drugs reduced L-type Ca 2+ current. In the case of CaCC inh -A01 the effects on L-506 type Ca 2+ current were minimal at 10 μM, only becoming evident at 30 μM, while in 507 the case of T16A inh -A01, 10 μM reduced L-type Ca 2+ current by 46%, while the 508 reduction at 30 μM was 78%. However, the L-type Ca 2+ current in corpus 509 cavernosum stood up to T16A inh -A01 more robustly than in A7r5 cells, where it was 510 reported that 1 μM T16A inh -A01 was sufficient to completely eliminate it (5), 511
suggesting that sensitivity varies between cell types. 512
The consequence of the tendency of the two compounds to block L-type Ca 2+ current 513 was evaluated by examining their effects on contractions evoked by 60 mM KCl in 514 the bath solution. Theoretically, 60 mM KCl should set the Nernst equilibrium 515 potential for K + (E K ) to about -22 mV, which is also close to the equilibrium potential 516
for Cl -in smooth muscle (1) . Under these conditions, one would expect the membrane 517 to be depolarized to a level determined by the equilibrium potentials of these two 518 most permeant ions. In this case, opening or blocking of Cl -channels would be 519 expected to have little effect on membrane potential, which would also be clamped 520 within the 'window current' range where L-type Ca 2+ current is constantly activated 521 (25). Under these conditions, CaCC inh -A01 (10 M) had a minimal effect on 522 contraction (Fig. 5) , which was in stark contrast to the effect of this concentration of 523 the drug on spontaneous and PE-enhanced contractions, which were reduced by 70% 524 & 80% respectively (Figs. 4 & 6) . Though CaCC inh -A01 (30 M) reduced the KCl 525 contracture by around 50%, consistent with its effects on L-type Ca 2+ current, both the 526 spontaneous and PE-enhanced contractions were abolished by this concentration. 527
Similarly, the spontaneous and PE-enhanced contractions were much more sensitive 528 than KCl contractures to T16A inh -A01. Overall, these results suggest that CaCC inh -529 A01 (10 M) blocks spontaneous and PE-enhanced contractions by a mechanism 530 other than blocking L-type Ca 2+ current, and even the actions of T16A inh -A01 cannot 531 wholly be accounted for by its blocking action on L-type Ca 2+ current. 532
From our data, CaCC inh -A01 seems the more specific of the two drugs and thus more 533 useful in evaluating the role of TMEM16A channels in in vitro muscle strips. 534
However, in a recent study, 10 M CaCC inh -A01 was reported to abolish 535 norepinephrine-induced contractions even in Cl -free conditions, suggesting to the 536 authors that its action could not wholly be accounted for by blocking Cl -channels (5). 537
In contrast, we found that the effect of 10 M CaCC inh -A01 was largely gone in Cl control; filled circles = CaCC inh -A01 (10 M), n=6. Inset shows the peak current in 730
control (1) 
